Furthermore, the tumor volume of the mice that received the multiantigen vaccine was significantly lower compared to the mice receiving the AMACR (p < 0.0001), HPN (p = 0.019) or the PSMA (p = 0.002) single antigen vaccines. The gene discussed is AMACR; the disease is neoplasm.